Molecular Pathology Competency: Biomarkers for Immunotherapy CORE
Description:
This is part of the Molecular Pathology Competency series which is composed of short videos focused on current topics on molecular pathology. Each topic will have a CORE and ADVANCED video. The CORE will cover core concepts while the ADVANCED video will discuss advanced applications and/or examples.
This core concept module provides information on the role of microsatellite status, tumor mutational burden levels and PD-L1 expression as biomarkers for immunotherapy of cancer.
  |
|---|
| Speaker Honey V. Reddi, PhD, FACMG |
Duration: 14 min
Level of Instruction: Basic
Audience: Practicing pathologists, as well as those seeking further/advanced training in specific areas of molecular pathology. This series will also benefit specialists in other pathology areas who are learning to sign out molecular results or are incorporating molecular findings into their reports. Molecular laboratory professionals, professionals in industry, and other interested individuals will find these modules of value for updating and broadening their scope of practice.
Access the ADVANCED topic here.
Access more in this series here.
There are no CME or CMLE available.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.